Source: Eur Respir J 2015; 45: 842-845
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Fukihara Jun, Kondoh Yasuhiro, Taniguchi Hiroyuki, Kimura Tomoki, Kataoka Kensuke, Matsuda Toshiaki, Yokoyama Toshiki, Ono Kenzo, Kashima Yukio, Fukuoka Junya. Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease. Eur Respir J 2015; 45: 842-845

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012 Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease Source: Eur Respir J 2009; 33: 1498-1502 Year: 2009 Pulmonary hypertension complicating fibrosing mediastinitis Source: International Congress 2016 – Clinic of pulmonary hypertension Year: 2016 Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension Source: Eur Respir Rev 2009; 18: 177-180 Year: 2009 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Pulmonary hypertension in patients with interstitial lung disease Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Cutaneous vascular spiders are associated with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009 Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Challenging cases in PH Source: Eur Respir Rev 2008; 17: 19-23 Year: 2007 Pulmonary hypertension due to lung disease Source: International Congress 2017 – Russian Programme 2017 Year: 2017 Pulmonary hypertension in interstitial lung diseases Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Pulmonary hypertension in interstitial lung disease Source: Eur Respir J 2008; 31: 1357-1367 Year: 2008 Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture Source: Eur Respir J 2009; 33: 666-669 Year: 2009 Non-pulmonary comorbidities in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Source: Eur Respir J 2005; 26: 586-593 Year: 2005 Biomarkers in pulmonary hypertension associated to interstitial lung disease Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012